The class I HDAC inhibitor Romidepsin targets inflammatory breast cancer tumor emboli and synergizes with paclitaxel to inhibit metastasis (Q39035013)
Jump to navigation
Jump to search
scientific article published on January 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The class I HDAC inhibitor Romidepsin targets inflammatory breast cancer tumor emboli and synergizes with paclitaxel to inhibit metastasis |
scientific article published on January 2013 |
Statements
1 reference
The class I HDAC inhibitor Romidepsin targets inflammatory breast cancer tumor emboli and synergizes with paclitaxel to inhibit metastasis (English)
1 reference
Fredika M Robertson
1 reference
Khoi Chu
1 reference
Kimberly M Boley
1 reference
Zaiming Ye
1 reference
Hui Liu
1 reference
Moishia C Wright
1 reference
Ricardo Moraes
1 reference
Xuejun Zhang
1 reference
Tessa L Green
1 reference
Sanford H Barsky
1 reference
Carla Heise
1 reference
Massimo Cristofanilli
1 reference
1 January 2013
1 reference
1 reference